Ki Jung Kim

Dr. Ki Jung Kim

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2025 in Science Advances
Verified
Journal Article
Open access
YSYoungsuk Seo
Youngsuk Seo
ISInwoong Song
Inwoong Song
KKKi Jung Kim
Ki Jung Kim
BCBomi Chang
Bomi Chang
PPPrajitha Pradeep
Prajitha Pradeep
BLBoyoung Lee
Boyoung Lee
Depression presents challenges in understanding its biological basis and developing effective treatments. Posttranslational modifications provide critical insights into molecular mechanisms of disorders, yet their role in depression remains underexplored. Glycosylation has been particularly difficult to study due to its heterogeneous nature and analytical challenges, despite its potential to uncover previously unknown mechanisms. In this study, we demonstrate how chronic stress alters region-specific O-glycosylation across multiple brain regions, with a particular focus on the prefrontal cortex (PFC). Our findings reveal significant changes in sialylated O-glycosylation patterns mediated by St3gal1 , a sialyltransferase essential for O-glycosylation. Notably, knockdown of St3gal1 in nonstressed mice induced depressive-like behaviors, whereas its overexpression in stressed mice alleviated depressive symptoms, underscoring its regulatory role in stress resilience. In addition, we identify potential glycoprotein targets and downstream regulators of St3gal1 , including neurexin 2 (NRXN2) in the medial PFC (mPFC), offering insights into molecular pathways linking O-glycosylation to depressive-like behaviors.

19 December 2024 in Neuroglia
Verified
Journal Article
Open access
PDF file
KKKi Jung Kim
Ki Jung Kim
RPRachel E Patterson
Rachel E Patterson
JDJuan Manuel Ramiro Diaz
Juan Manuel Ramiro Diaz
POPhilip O'Herron
Philip O'Herron
WBWeston Bush
Weston Bush
JFJessica Andrea Filosa
Jessica Andrea Filosa
Background: Chronic hypoperfusion is a risk factor for neurodegenerative diseases. However, the sequence of events driving ischemia-induced functional changes in a cell-specific manner is unclear. Methods: To address this gap in knowledge, we used the bilateral common carotid artery stenosis (BCAS) mouse model, and evaluated progressive functional changes to neurons, arterioles, astrocytes, and microglial cells at 14 and 28 days post-BCAS surgery. To assess the neuro-glio-vascular response to an acute ischemic insult, brain slices were superfused with low O2 conditions. Using whole-cell patch-clamp electrophysiology, we measured basic membrane properties (e.g., resting membrane potential, capacitance, input resistance) in cortical pyramidal neurons. The activity of astrocytes was evaluated by monitoring Ca2+ from Aldh1l1-CreERT2; R26-lsl-GCaMP6f mice. Vascular reactivity to low O2 from the BCAS mice was also assessed ex vivo. Results: Our data showed no changes to the basic membrane properties of cortical pyramidal neurons. On the other hand, astrocyte activity was characterized by a progressive increase in the resting Ca2+. Notably, at 14 and 28 days post-BCAS, there was an increased expression of anti-inflammatory-related markers (IL-10, S100A10, TRPA1, and Nrf2). These data suggest that, in young mice, BCAS-induced increases in resting Ca2+ were associated with the expression of neuroprotective signals. Contrary to observations in glial cells, vascular function was impaired post-BCAS surgery, as shown by a blunted vasodilatory response to low O2 and the vasodilatory signal, adenosine. Conclusions: Together, these data suggest that, in young mice, BCAS leads to vascular dysfunction (e.g., impaired vasodilation in parenchymal arterioles), and in the absence of neuronal dysfunction, mild ischemia is associated with the activation of glial-derived neuroprotective signals.

3 April 2026 in Nature Communications
Verified
Journal Article
Open access
YLYoungeun Lina Lee
Youngeun Lina Lee
MRMaria Reva
Maria Reva
KKKi Jung Kim
Ki Jung Kim
HKHyun-Jin Kim
Hyun-Jin Kim
YKYemin Kim
Yemin Kim
JJae-Ick Kim
Jae-Ick Kim
Dopamine affects voluntary movement by modulating basal ganglia function. However, the contribution of dopamine on striatopallidal synapses, an initial hub in the indirect pathway connecting the striatum to the GPe, remains poorly understood because of the sparse dopaminergic innervation. Here, we combine optogenetic projection targeting, whole cell patch clamp recordings in acute brain slices from mice, and computational modeling to overcome this limitation. We show that dopamine activates D2 receptors (D2Rs) and D4 receptors (D4Rs) differentially in distinct GPe subregions. In a pinwheel-like fashion, dorsolateral and ventromedial GPe expresses high levels of D2Rs, which exert presynaptic inhibition, while in dorsomedial and ventrolateral GPe D4Rs cause postsynaptic inhibition. Dopamine depletion by 6-OHDA reshapes the region-specific effect of dopamine, shifting it in the opposite direction and contributing to hypokinesia. These findings reveal the mechanism by which the different modality information conveyed spatially through the indirect pathway is differentially modulated by dopamine at striatopallidal synapses.

26 February 2025 in Glia
Verified
Journal Article
Closed access
KKKi Jung Kim
Ki Jung Kim
JLJae‐Hun Lee
Jae‐Hun Lee
JLJiwoon Lim
Jiwoon Lim
TLTaehee Lee
Taehee Lee
JJJinhyeong Joo
Jinhyeong Joo
CLC. Justin Lee
C. Justin Lee

5 November 2026 in Experimental & Molecular Medicine
Verified
Journal Article
Open access
PDF file
SKSu Min Kang
Su Min Kang
DKDae-Si Kang
Dae-Si Kang
TCTae-Yong Choi
Tae-Yong Choi
SJSejin Jeong
Sejin Jeong
ALA-Hyeon Lee
A-Hyeon Lee
JKJa Wook Koo
Ja Wook Koo
Psilocybin is a serotonergic hallucinogen that acts primarily through 5-HT₂A receptor signaling, yet the mechanisms by which it regulates mesolimbic inhibitory tone remain poorly understood. Here we investigated how psilocybin and structurally related synthetic tryptamines modulate inhibitory signaling in the nucleus accumbens (NAc) and whether astrocyte-associated mechanisms contribute to this process. Psilocybin-like tryptamines that generalized to the psilocybin cue increased NAc neuronal activity while reducing extracellular GABA levels, identifying diminished NAc GABAergic tone as a neurochemical correlate of psilocybin-like behavioral responses. Consistent with this interpretation, local pharmacological modulation of NAc GABA receptor signaling altered psilocybin-appropriate responding. We next examined the cellular and molecular basis of this GABAergic regulation. Ex vivo whole-cell recordings revealed that psilocin, the active metabolite of psilocybin, reduced tonic GABA current in NAc medium spiny neurons without affecting miniature inhibitory postsynaptic currents, indicating preferential modulation of tonic rather than miniature synaptic inhibition. Cell-type-specific analyses further showed that psilocybin selectively reduced intracellular GABA levels in astrocytes, but not neurons. Psilocybin increased astrocytic NFATc4 and ALDH5A1 protein expression together with enhanced H3K27 acetylation, and ChIP–qPCR analysis showed increased NFATc4 occupancy at the Aldh5a1 promoter. Consistent with upstream serotonergic signaling, psilocin-induced calcium responses in astrocytes were attenuated by 5-HT₂A receptor antagonism. Together, these findings support a model in which psilocybin modulates mesolimbic inhibitory tone through astrocyte-associated regulation of NAc GABA homeostasis. Our findings further identify astrocytic NFATc4-associated transcriptional regulation as a mechanism linked to ALDH5A1 expression, astrocytic GABA homeostasis and tonic inhibitory regulation in the NAc.

29 September 2026 in Advanced Science
Verified
Journal Article
Open access
PDF file
KHKayoung Han
Kayoung Han
MJMinwoo Wendy Jang
Minwoo Wendy Jang
TPTaeyoung Park
Taeyoung Park
KKKi Jung Kim
Ki Jung Kim
VDVictor James Drew
Victor James Drew
CLC. Justin Lee
C. Justin Lee
Astrocytes are recognized as key components of neurovascular coupling (NVC), yet whether and how astrocytic engagement in NVC depends on sensory stimulus duration remains unclear. Here, we investigated a duration‐dependent astrocytic mechanism underlying cerebral blood volume (CBV) modulation by comparing neurovascular responses to brief (5 s) and prolonged (20 s) sensory stimulation, using in vivo intrinsic optical signal (IOS) imaging and two‐photon microscopy combined with electrophysiology and vascular cannulation. We show that prolonged stimulation selectively recruits an integrated astrocytic signaling cascade involving aquaporin‐4 (AQP4)‐mediated volume changes, Ca 2+ influx through mechanosensitive transient receptor potential ankyrin 1 (TRPA1), and D‐serine release through the Ca 2+ ‐dependent Bestrophin‐1 (BEST1) channel. This signaling cascade drives sustained neuronal activity, leading to CBV modulation and sensory perception. Genetic ablation of each component in this pathway selectively impairs CBV responses, neuronal activity, and sensory behavior during prolonged stimulation, while exogenous D‐serine fully restores these deficits. We further demonstrate that tonic astrocytic D‐serine release via BEST1 directly regulates the basal tone of penetrating arterioles. These findings together identify astrocytic D‐serine as one of the key gliotransmitters that modulate CBV and neuronal activity during prolonged sensory demand and fine‐tune vascular tone in resting states.